Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-082251
Filing Date
2026-02-27
Accepted
2026-02-27 15:15:25
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11343
  Complete submission text file 0001193125-26-082251.txt   12960
Mailing Address C/O KURA ONCOLOGY, INC. 4930 DIRECTORS PLACE, SUITE 500 SAN DIEGO CA 92121
Business Address
WILSON TROY EDWARD (Reporting) CIK: 0001589597 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39321 | Film No.: 26698725

Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)